Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660887 · ClinicalTrials.gov registry record
Olfactory Dysfunction in Aging Adults
A clinical trial, sponsored by Medical University of South Carolina.
- Not yet
- Registry status
- 500
- Enrollment target
NCT07660887: Clinical Trial study, sponsored by Medical University of South Carolina.
NCT07660887 is a clinical trial that has not yet begun recruiting, run by Medical University of South Carolina. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07660887 has not yet begun recruiting, sponsored by Medical University of South Carolina.
- NOT YET RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
This prospective longitudinal cohort study will enroll adults aged 50 years and older to characterize olfactory dysfunction in aging. Participants will undergo comprehensive olfactory testing, cognitive assessment, biomarker collection, and imaging to identify clinically relevant phenotypes based on anatomic site of dysfunction. The study will also evaluate the impact of olfactory dysfunction on quality of life and identify baseline factors associated with changes in olfactory function over time.
Primary Outcome
Olfactory Threshold, Discrimination, and Identification (TDI scores) using Sniffin' Sticks.
Interventions
- OTHER Clinical and Biomarker Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2027-04-01 |
| Est. Completion | 2032-04-30 |
What is known before NCT07660887 opens enrollment
NCT07660887 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Clinical and Biomarker Assessments is the first listed.
NCT07660887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07660887 about?
NCT07660887 is a clinical study titled "Olfactory Dysfunction in Aging Adults". This prospective longitudinal cohort study will enroll adults aged 50 years and older to characterize olfactory dysfunction in aging. Participants will undergo comprehensive olfactory testing, cognitive assessment, biomarker collection, and imaging to identify clinically relevant phenotypes based on...
What is the current status of trial NCT07660887?
This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2027-04-01. Estimated completion is 2032-04-30.
What interventions are being tested in trial NCT07660887?
The interventions under investigation include: Clinical and Biomarker Assessments (OTHER).
Who is sponsoring clinical trial NCT07660887?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI